About this trial
Transcutaneous capnometry (tPCO₂) is a non-invasive method for continuous monitoring of ventilation status. In pediatric intensive care patients, it may reduce the need for repeated arterial or arterialized blood sampling. However, the accuracy of tPCO₂ may be influenced by factors such as peripheral perfusion, skin temperature, and vasopressor therapy. This prospective observational study compares transcutaneous carbon dioxide measurements with arterialized or arterial blood gas PaCO₂ values in children with respiratory insufficiency, including a subgroup receiving vasopressor support.
Eligibility criteria
Qualifiers
Age 1-18 years
Diagnosis of respiratory insufficiency or impaired peripheral perfusion
Expected need for more than one arterialized capillary or arterial blood gas sample
Admission to PICU
Disqualifiers
Repeated failure of sensor adhesion
Hypothermia < 35 °C
Time difference > ±5 minutes between tPCO₂ and blood sampling
Large tPCO₂ variability (> ±1 kPa) in 15 minutes preceding blood sampling
Trial design
Treatments tested in this trial
- Not listed